Developing Cancer Vaccines to Target the Tumor Microenvironment with Mai-Britt Zocca IO Biotech TRANSCRIPT
Download PDFJun 8, 2022
Mai-Britt Zocca is the Founder, CEO, and President of IO Biotech, a clinical stage biopharmaceutical company headquartered in Denmark. They are developing immune modeling cancer therapies based on their T-win technology. Using these cancer vaccines, pre-existing T-cells are being directed in patients to attack and...
Jun 8, 2022
Mai-Britt Zocca is the Founder, CEO, and President of IO Biotech, a clinical stage biopharmaceutical company headquartered in Denmark. They are developing immune modeling cancer therapies based on their T-win technology. Using these cancer vaccines, pre-existing T-cells are being directed in patients to attack and...
Radiopharmaceutical Technology Creates Novel Radioantibodies to Treat Prostate Cancer with Dr. Phil Kantoff and Alex Brown Convergent Therapeutics TRANSCRIPT
Download PDFMay 30, 2022
Dr. Phil Kantoff is the CEO and Co-Founder and Alex Brown is the COO of Convergent Therapeutics which is developing the next generation of targeted therapies to treat cancer. Drawing on insights from developments in radiopharmaceuticals, Convergent focuses on radioantibodies that are radioisotopes attached to antibodies...
May 30, 2022
Dr. Phil Kantoff is the CEO and Co-Founder and Alex Brown is the COO of Convergent Therapeutics which is developing the next generation of targeted therapies to treat cancer. Drawing on insights from developments in radiopharmaceuticals, Convergent focuses on radioantibodies that are radioisotopes attached to antibodies...
Using Noninvasive Genomics Platform to Identify Skin Cancer Creating Paradigm Shift for Dermatological Care with Dr. John Dobak DermTech TRANSCRIPT
Download PDFMar 10, 2022
Dr. John Dobak is the President and CEO of DermTech which is leading the genomic revolution in dermatology to more accurately determine the presence of skin cancer. Their noninvasive platform changes the protocol for assessing a suspicious mole from visual review and surgically removing tissue to genomic analysis and...